EPHARPLUS - Key Persons

Mr. Wei LI has served different roles in international collaboration in industry since 2002. He joined KPC Pharmaceuticals in 2015, acted as Director of Business Development focusing on outbound investment and in-licensing innovative products for the company. Prior to this, he worked in several subsidiary pharmaceutical companies in Holley Group, with comprehensive responsibilities to promote innovative artemisinin based antimalarials accepted by World Health Organization and global bulk purchasers.